Individuals who have suffered revision surgeries and pain and suffering from DePuy’s flawed ASR Hip Implant stand to receive a settlement – as DePuy parent company Johnson & Johnson has agreed to pay about $2.5 billion to compensate 8,598 patients.
The New York Times reports that, under the settlement agreement, Johnson & Johnson will cover an additional $3 billion to cover medical costs of the procedures.
This settlement seeks to address the claims of those ASR patients who have undergone a revision surgery as of August 31, 2013 and allows ASR patients who have yet to undergo a revision surgery to maintain their legal rights.
The deal was announced in open court on November 19, when the federal district court judge overseeing, MDL 2197, the DePuy ASR multi-district litigation, Hon. David A. Katz in Ohio held a hearing to consider the proposal.
In order to finally settle, at least 94% of the eligible claimants must agree to the deal. In order to particpate, a patient must be a U.S. citizen or resident who has had the ASR XL Acetabular Hip System or the ASR Hip Resurfacing system implanted in a U.S. Hospital or U.S. Military Hospital. The typical patient will receive about $250,000 before attorneys fees are calculated.
Sheller, P.C. represents numerous plaintiffs in the ASR litigation and settlement. If you have a DePuy ASR metal-on-metal implant and have questions about your rights under the settlement, please call us at (800) 883-2299.
Click Here to read the transcript of the settlement conference.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.